2-ETHYNYLQUINOLINE, 95%, 1g

3-Oxo-3,4-dihydroquinoxaline-6-carboxylic acid, 95+%, 100mg

[4-(methoxycarbonyl)-1H-pyrazol-1-yl]acetic acid, 1g

Piperidina, PEPTIPURE®, minimo 99,5%, per la sintesi di peptidi, 2,5 l, confezione in vetro

(S)-Benzyl 2-methyl-3-oxoazetidine-1-carboxylate, 98%, 5g

5,5-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-2-en-1-one, 98%, 100mg

[5-chloro-2-(difluoromethoxy)phenyl]methanol, 95%, 100mg

TASQUINIMOD, 95%, 10mg

4-Bromo-3,5-dimethylaniline, 95.0%, 25g

1-(1-Methyl-1H-indazol-4-yl)ethanone, 95.0%, 500mg

Ethyl N-Boc-4-fluoropiperidine-4-carboxylate, 95.0%, 25g

4-(1-Chloro-2-(methylamino)ethyl)phenyl acetate hydrochloride, 95.0%, 100mg

N1,N1-Dimethylbiguanide hydrochloride, 95.0%, 25g